DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20214218

Counseling in psoriasis: overcoming the concerns and challenges

Kiran Godse, S. G. Parasramani, Abhishek De, Nitesh Kumar Singh, Pallavi Kawatra

Abstract


Psoriasis is a systemic, immune-mediated disorder, characterized by systemic inflammation predominantly in skin and joints with significant physical and psychosocial consequences. It is a chronic disease with an unpredictable journey consisting of flares and remissions.  Psoriasis has also been linked to loss of self-esteem in patients, depression and suicidal tendencies. In addition, it also contributes to financial burden due to the long-term management. This results in negative impact on the caregivers and family of the patient. Due to these multiple factors, there has been low compliance to therapy and higher likelihood of discontinuation of treatment. Considering the emotional aspect involved in this disease, counseling of the patients becomes one of the integral pillars for the management of the disease. Hence, the clinician’s role becomes significant, due to limited access to counselors, therapists and social groups, in our country. The present reviewdescribes the impact of psoriasis on the patient’s life and the practical approaches that may be taken to counsel the patient of psoriasis.


Keywords


Psoriasis, Depression, Suicidal tendencies, Anxiety

Full Text:

PDF

References


Dogra S, Yadav S. Psoriasis in India: Prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595.

WHO. Global report on psoriasis. 2016.

Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Academy Dermatol Venereol. 2012;26:3-11.

Larsen MH. Educational and self-management interventions for patients with psoriasis in the context of climate/heliotherapy. 2015;73-9.

Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, comorbidities, and clinical scoring. Indian dermatol online j. 2016;7(6):471.

Belge K, Brück J, Ghoreschi K. Advances in treating psoriasis. F1000Prime Rep. 2014;6:4.

De Korte J, Mombers FM, Bos JD, Sprangers MA, editors. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140-7.

Murlidhar R, Chatterjee M, Abhishek D, Dogra S, Ganguly S, Kar BR et al. ACTNOW: Therapeutic Inertia in management of psoriasis and its impact on patients. Maui Derm Conference. 2021;12(5):674-82.

Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ open. 2015;5:1.

Sarkar R, Chugh S, Bansal S. General measures and quality of life issues in psoriasis. Indian dermatol online j. 2016;7(6):481.

Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health quality life outcomes. 2006;4(1):35.

Debra Wood R. Average Time Doctors Spend With Patients: What’s the Number for Your Physician Specialty? Medscape’s 2017 Physician Compensation Report. 2017.

CORPORATION C. Why People with Plaque Psoriasis Should See Their Doctors Frequently. Responsibility Psoriasis. 2018.

Hägg D, Sundström A, Eriksson M, Schmitt-Egenolf M. Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish register patients. Am J Clin Dermatol. 2017;18(4):583-90.

Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch dermatol. 2010;146(8):891-5.

Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int j dermatol. 1993;32(3):188-90.

Lakshmy S, Balasundaram S, Sarkar S, Audhya M, Subramaniam E. A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis. Indian J Psychol Med. 2015;37(4):434-40.

Wu Y, Mills D. Bala M. Impact of Psoriasis on Patients’ Work and Productivity. AM J Clin Dermatol. 2009;10:407-10.

Rodriguez-Bolanos F, Gooderham M, Papp K. A Closer Look at the Data Regarding Suicidal Ideation and Behavior in Psoriasis Patients: The Case of Brodalumab. Skin Therapy Lett. 2019;24:1-4.

Svanström C, Lonne-Rahm S-B, Nordlind K. Psoriasis and alcohol. Psoriasis (Auckl). 2019;9:75-9.

Panasiti MS, Ponsi G, Violani C. Emotions, Alexithymia, and Emotion Regulation in Patients With Psoriasis. Frontiers Psychol. 2020;11:836.

Cai Q, Teeple A, Wu B, Muser E. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. J Med Economics. 2019;22(12):1290-7.

Uttjek M, Nygren L, Stenberg B, Dufåker M. Marked by visibility of psoriasis in everyday life. Qualitative health res. 2007;17(3):364-72.

Day DD. 10 Questions Your Dermatologist Wants You to Ask About Psoriasis. 2020.

Boehncke WH, Anliker MD, Conrad C, Dudler J, Hasler F, Hasler P et al. The dermatologists’ role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists. Dermatology (Basel, Switzerland). 2015;230(1):75-81.

Psoriasis?” AAoDWi, National Psoriasis Foundation: “Itch Relief YDaPMOW-B,” “Sunlight and Other Psoriasis Treatments,” “Time to Kick the Habit? Thinking Twice About Alcohol and Cigarettes.”. Questions to Ask Your Doctor About Psoriasis Treatments WebMD Medical Reference. Available at: https://www.webmd.com/skin-problems-and-treatments/psoriasis/questions;. Accessed on June 20, 2019.

Truong B, Rich-Garg N, Ehst B, Deodhar AA, Ku J, Vakil-Gilani K et al. Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis. Clin cosmetic investigational dermatol. 2015;8:563.

Nazeer M, Ravindran S, Gangadharan G, Criton S. A survey of treatment practices in management of psoriasis patients among dermatologists of Kerala. Indian Dermatol Online J. 2019;10:437-40.

Shah K and Garg S. Patient advocacy groups: Need and opportunity in India. Perspect Clin Res. 2011;2(1):4-7.

Feldman SR, Burudpakdee C, Gala S, Nanavaty M, Mallya UG. The economic burden of psoriasis: a systematic literature review. Expert review of pharmacoeconomics outcomes res. 2014;14(5):685-705.

National health portal. Psoriasis. Government of India. Available at: https://www.nhp.gov.in/ disease/skin/psoriasis. Accessed on: December 23, 2020.

Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. How does stigma affect people with psoriasis? Adv Dermatol Allergol/Postȩpy Dermatol Alergol. 2017;34(1):36.

Hafi B, Abdul Latheef EN, Uvais N. Awareness of psychodermatology in Indian dermatologists: A South Indian perspective. Dermatologic Therapy. 2020;33:e14024.